Elevated dopamine signaling from ventral tegmental area to prefrontal cortical parvalbumin neurons drives conditioned inhibition

Conditioned inhibition is an important process to suppress learned responses for optimal adaptation, but its underlying biological mechanism is poorly understood. Here we used safety learning (SL)/fear discrimination after fear conditioning as a conditioned inhibition model because it demonstrates t...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 116; no. 26; pp. 13077 - 13086
Main Authors: Yan, Rongzhen, Wang, Tianyu, Zhou, Qiang
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 25-06-2019
Series:PNAS Plus
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conditioned inhibition is an important process to suppress learned responses for optimal adaptation, but its underlying biological mechanism is poorly understood. Here we used safety learning (SL)/fear discrimination after fear conditioning as a conditioned inhibition model because it demonstrates the essential properties of summation and retardation. Activity of the dorsomedial prefrontal cortex (dmPFC) parvalbumin (PV) neurons bidirectionally regulates spiking levels of dmPFC excitatory neurons and fear states. Responses to safety cues are increased in dopaminergic (DA) neurons in the ventral tegmental area (VTA) and in PV neurons in dmPFC after SL. Plasticity in the VTA is implicated, since SL requires activation of N-methyl-D-aspartate receptors. Furthermore, in a posttraumatic stress disorder model, impaired SL is associated with impaired potentiation of VTA DA neuron activity. Our results demonstrate a DA-dependent learning process that targets prefrontal inhibitory neurons for suppression of learned responses, and have implications for the pathogenesis and treatment of various psychiatric diseases.
Bibliography:Edited by Robert Malenka, Stanford University School of Medicine, Stanford, CA, and approved May 16, 2019 (received for review January 31, 2019)
Author contributions: R.Y. and Q.Z. designed research; R.Y., T.W., and Q.Z. performed research; R.Y., T.W., and Q.Z. analyzed data; and R.Y. and Q.Z. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1901902116